Title: Translational medicine in the prediction of clinical drug response

Speaker: Dr. R. Stephanie Huang

                 Assistant Professor of Medicine,

                 Comprehensive Cancer Center,

                 Center for Personalized Therapeutics,

                 Committee on Cancer Biology at the University of Chicago

Host: Dr.MI Shuangli

Time: 9:30-11:00, Sep 30th, 2014

Location: First-floor seminar hall, Conference Room, BIG, CAS

Introduce: To develop clinically useful models that predict risks for adverse drug reactions and non-response prior to administration of chemotherapy, Dr. Huang’ Lab research focuses on translational pharmacogenomic research with particular interest in the pharmacogenomics of anticancer agents by systematically evaluating the human genomes and their relationships to drug response and toxicity. They utilize cell lines, and clinical samples to discover and functional characterize genetic variations, gene and microRNA (miRNA) expression for their role in chemotherapeutic sensitivity.